We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRW icon
476
C.H. Robinson
CHRW
$20.1B
$259K 0.08%
+2,994
New +$251K
HCC icon
477
Warrior Met Coal
HCC
$4.17B
$258K 0.08%
+4,228
New +$223K
USLM icon
478
United States Lime & Minerals
USLM
$3.38B
$256K 0.08%
+5,565
New +$236K
PLTR icon
479
Palantir
PLTR
$296B
$256K 0.08%
14,913
-34,263
-70% -$610K
ISRG icon
480
Intuitive Surgical
ISRG
$130B
$256K 0.08%
+758
New +$226K
LEG icon
481
Leggett & Platt
LEG
$1.47B
$256K 0.08%
+9,770
New +$240K
CARR icon
482
Carrier Global
CARR
$52.1B
$256K 0.08%
+4,448
New +$235K
OFIX icon
483
Orthofix Medical
OFIX
$496M
$253K 0.08%
18,766
+4,294
+30% +$50.5K
TBRG
484
DELISTED
TruBridge
TBRG
$253K 0.08%
+22,584
New +$286K
SBGI icon
485
Sinclair Inc
SBGI
$1.02B
$253K 0.08%
19,385
+1,376
+8% +$16.9K
CNNE icon
486
Cannae Holdings
CNNE
$671M
$252K 0.08%
+12,919
New +$235K
AMRX icon
487
Amneal Pharmaceuticals
AMRX
$5.95B
$250K 0.08%
41,194
+28,155
+216% +$125K
BLMN icon
488
Bloomin' Brands
BLMN
$740M
$249K 0.08%
+8,839
New +$215K
CTS icon
489
CTS Corp
CTS
$1.83B
$247K 0.07%
+5,650
New +$228K
JOBY icon
490
Joby Aviation
JOBY
$7.1B
$247K 0.07%
+37,140
New +$229K
SEAT icon
491
Vivid Seats
SEAT
$87.9M
$246K 0.07%
+1,949
New +$267K
MMS icon
492
Maximus
MMS
$3.29B
$246K 0.07%
2,932
-602
-17% -$48K
AORT icon
493
Artivion
AORT
$1.32B
$246K 0.07%
+13,751
New +$214K
PAHC icon
494
Phibro Animal Health
PAHC
$1.47B
$246K 0.07%
+21,221
New +$240K
PFSI icon
495
PennyMac Financial
PFSI
$4.46B
$246K 0.07%
+2,780
New +$209K
CAH icon
496
Cardinal Health
CAH
$54.5B
$243K 0.07%
2,407
-2,419
-50% -$240K
HSTM icon
497
HealthStream
HSTM
$839M
$242K 0.07%
8,939
-3,581
-29% -$89K
MTN icon
498
Vail Resorts
MTN
$5.53B
$241K 0.07%
+1,131
New +$248K
AEHR icon
499
Aehr Test Systems
AEHR
$2.24B
$241K 0.07%
+9,084
New +$265K
SNDR icon
500
Schneider National
SNDR
$6.37B
$241K 0.07%
9,460
-155
-2% -$3.82K
18 19
20
21 22

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.